| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 03/24/2004 | EP1400515A1 Cyclic diamine compound having five-membered cyclic group |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 03/24/2004 | EP1399416A2 Peptide deformylase inhibitors |
| 03/24/2004 | EP1399163A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 03/24/2004 | EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2004 | EP1399137A1 Sulfonamides |
| 03/24/2004 | EP1143964B1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/24/2004 | EP1140895B1 Thiopyran compounds as inhibitors of mmp |
| 03/24/2004 | CN1142936C Condensed thienopyrimidines with phosphodiesterase-V inhibiting action, preparation process and use thereof |
| 03/24/2004 | CN1142929C Process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene |
| 03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/23/2004 | US6710205 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient |
| 03/23/2004 | US6710190 3-heteroarylalkyl substituted gaba analogs |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 03/23/2004 | US6710072 Vision defects |
| 03/23/2004 | US6710071 Such as ((3-4-(difluoro(phenyl)methyl)phenoxyl-3-phenylpropyl)methylamino)acetic acid; for the enhancement of cognition and the treatment of scizophrenia and other psychoses |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/18/2004 | WO2004022534A1 Arylglycine derivatives for use as glycine transport inhibitors |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022525A1 Amide derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
| 03/18/2004 | US20040054003 Pgd2 receptor antagonistic pharmaceutical compositions |
| 03/18/2004 | US20040053983 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 03/18/2004 | US20040053382 Oxidizing an alpha-amino-carboxylic acid, hydrate, or salt thereof using a L-amino acid deaminase or oxidase and subsequently reducing the product thereof using a dehydrogenase |
| 03/18/2004 | US20040053330 Amino polyols and amino sugars |
| 03/18/2004 | US20040053158 Onium salts and the use therof as latent acids |
| 03/18/2004 | DE10241287A1 New 9-benzylidene-naphtho-(2,3-b)-thiophen-4-ones, are potent tubulin polymerization inhibitors useful for treating proliferative diseases, especially cancer |
| 03/18/2004 | CA2501924A1 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | CA2499380A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/17/2004 | EP1398341A2 Organic compounds with core-shell structure |
| 03/17/2004 | EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 03/17/2004 | EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy |
| 03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/17/2004 | EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| 03/17/2004 | EP1397129A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors |
| 03/17/2004 | EP1334095A4 Process for the preparation of pgd2 antagonist |
| 03/17/2004 | EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1008594B1 Compounds derived from thophene and benzothiophene, and related utilisation and composition |
| 03/17/2004 | CN1482907A Compounds having fungicidal activity and processes to make and use same |
| 03/17/2004 | CN1482122A Intermediates for producing 2-thiosubstituted carbapenems |
| 03/17/2004 | CN1142157C Thenoyl piperazine derivative with positive myodyamia effect |
| 03/16/2004 | US6706917 Decyclization and deesterification of 5,6-dihydro-2(4h)-benzofuranone in presence of organic acid metal salt catalyst |
| 03/16/2004 | US6706895 Chemical intermediates for bifenazate |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706755 For treating ocular hypertension or glaucoma |
| 03/16/2004 | US6706754 Antiprotozoa agents, parasiticides |
| 03/16/2004 | US6706744 Hypoglycemic agents; antidiabetic agents |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706715 Reversible inhibitors of the blood clotting enzyme factor viia |
| 03/13/2004 | CA2440307A1 Organic compounds having a core-shell structure |
| 03/11/2004 | WO2004020445A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 03/11/2004 | WO2004020444A1 New 3,4-alkylenedioxythiophenedioxide compounds and polymers comprising monomeric units thereof |
| 03/11/2004 | WO2004020402A1 Sulphonylamino derivatives for the treatment of alzheimer's disease |
| 03/11/2004 | WO2004020391A1 Method for the production of monoalkylamino ketones |
| 03/11/2004 | WO2004020389A1 Method for the enantioselective hydrogenation of amino alcohols |
| 03/11/2004 | WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2003082861A3 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2003002524A3 Urea derivatives with antiproteolytic activity |
| 03/11/2004 | US20040049072 RXR modulators with improved pharmacologic profile |
| 03/11/2004 | US20040049071 Contacting non-fluorous phase with fluorous phase at first phase interface; fluorous-tagged compound distributes between the phases; and contacting fluorous phase with second non-fluorous phase at a second phase interface. |
| 03/11/2004 | US20040049040 Pohtochromic material |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040048895 Caspase-1 inhibitors and methods for their use |
| 03/11/2004 | US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics. |
| 03/11/2004 | US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040048102 For use in the areas of indicators, displays, backlight, electrophotography, illumination sources, recording light sources, exposure illuminants, reading light sources, beacons, signboards and interiors |
| 03/11/2004 | DE10240026A1 Verfahren zur Herstellung von Monoalkylaminoketonen A process for preparing Monoalkylaminoketonen |
| 03/11/2004 | DE10237272A1 Preparation of optically pure (3RS)-2-oxy-3-(2-thienyl)-propylamine compound, useful as drug intermediate for e.g. serotonin and norepinephrine uptake inhibitor duloxetine, by enantioselective Reformatsky type synthesis via new intermediate |
| 03/11/2004 | CA2497028A1 Process for the preparation of monoalkylaminoketones |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395567A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395552A2 Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | EP1395263A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |